Figure 1.

a, Section in Breast Tissue Showing Benign Fibrocystic Changes (Hematoxylin and eosin stain, X100); b, section in case of fibrocystic disease showed negative RAGE expression in ductal epithelium (IHC for RAGE, X100); c, Section in breast tissue showing Duct Carcinoma In Situ (DCIS), with cribriform pattern (Hematoxylin and eosin stain, X100), d, section in duct carcinoma showing weak expression for RAGE (IHC for RAGE, X100); e, Section in breast tissue showing Invasive Duct Carcinoma (IDC) of moderate differentiation (G2) (Hematoxylin and eosin stain, X200); f, a case of invasive duct carcinoma showing positive expression for RAGE in tumor cells (IHC for RAGE, X200).